1 – 10 of 37
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
The fifth international hackathon for developing computational cloud-based tools and resources for pan-structural variation and genomics
(
- Contribution to journal › Article
-
Mark
Digital PCR quantification of ultrahigh ERBB2 copy number identifies poor breast cancer survival after trastuzumab
(
- Contribution to journal › Article
-
Mark
Proteomic profiling reveals that ESR1 mutations enhance cyclin-dependent kinase signaling
(
- Contribution to journal › Article
- 2023
-
Mark
805P Tumor-informed ctDNA detection as a predictive marker for postoperative residual disease in epithelial ovarian cancer: A feasibility study
(
- Contribution to journal › Published meeting abstract
-
Mark
#898 Tumor-informed ctDNA detection as a marker for postoperative residual disease in epithelial ovarian cancer : results of a feasibility study
(
- Contribution to journal › Published meeting abstract
-
Mark
Abstract 5710: Detection and monitoring of t(11;14) in liquid biopsies from patients with relapsed/refractory multiple myeloma treated with venetoclax-based regimens
(
- Contribution to journal › Published meeting abstract
-
Mark
Preoperative ctDNA Levels Are Associated With Poor Overall Survival in Patients With Ovarian Cancer
(
- Contribution to journal › Article
- 2022
-
Mark
Molecular and Serologic Diagnostic Technologies for SARS-CoV-2
2022) In arXiv.org(
- Working paper/Preprint › Preprint in preprint archive
-
Mark
PrecisionFDA Truth Challenge V2: Calling variants from short and long reads in difficult-to-map regions
(
- Contribution to journal › Article
-
Mark
Clinical associations of ESR2 (estrogen receptor beta) expression across thousands of primary breast tumors
(
- Contribution to journal › Article